CHP
MDCO

Cable Hill Partners’s Medicines Co MDCO Stock Holding History

Cable Hill Partners’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-57
Closed -$2K – 999
2017
Q4 		$2K Sell
57
-78
-58% -$2.4K ﹤0.01% 888
2017
Q3 		$5K Sell
135
-3
-2% -$111 ﹤0.01% 788
2017
Q2 		$5K Hold
138
– – ﹤0.01% 575
2017
Q1 		$7K Buy
138
+73
+112% +$3.33K ﹤0.01% 487
2016
Q4 		$2K Sell
65
-76
-54% -$2.69K ﹤0.01% 673
2016
Q3 		$5K Sell
141
-15
-10% -$565 ﹤0.01% 589
2016
Q2 		$6K Hold
156
– – ﹤0.01% 486
2016
Q1 		$5K Buy
156
+1
+0.6% +$33 ﹤0.01% 493
2015
Q4 		$6K Hold
155
– – ﹤0.01% 451
2015
Q3 		$6K Buy
+155
New +$5.44K ﹤0.01% 478

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Cable Hill Partners's MDCO Position: Q1 2018 in Review

Cable Hill Partners sold out of Medicines Co (MDCO) in Q1 2018, closing a stake of 57 shares — an estimated $2K sold.

Cable Hill Partners first reported a position in MDCO in Q3 2015 and held it in 10 quarters. The position peaked at $7K in Q1 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q1 2018.

  • Cable Hill Partners reported no remaining Medicines Co position as of Q1 2018 after selling out during the quarter.
  • Cable Hill Partners sold 57 Medicines Co shares in Q1 2018, an estimated $2K.
  • Cable Hill Partners first reported a position in Medicines Co in Q3 2015 and held it in 10 quarters.
  • Cable Hill Partners's Medicines Co position peaked at $7K in Q1 2017.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q1 2018.

Based on Cable Hill Partners's 13F filing for Q1 2018, filed 20 Apr 2018.